Literature DB >> 8417831

Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts.

T Asplund1, M A Versnel, T C Laurent, P Heldin.   

Abstract

The hyaluronan production by three human malignant mesothelioma cell lines and nine primary human mesothelial cell types was determined. The mesothelioma cell lines produced only minute amounts of hyaluronan (less than 0.1 microgram/10(6) cells/48 h) whereas mesothelial cells synthesized large quantities of hyaluronan (10-72 micrograms/10(6) cells/48 h). Conditioned media from the mesothelioma cell lines were investigated for their ability to stimulate hyaluronan production by fibroblasts and mesothelial cells in vitro, and in all cases stimulatory effects were found. The factor(s) in the conditioned medium of the mesothelioma cell line Mero-25 that were responsible for hyaluronan stimulation were heat stable and partially trypsin resistant. The stimulatory activity was partially inhibited by an antiserum against platelet-derived growth factor and basic fibroblast growth factor. Our data suggest that the increased hyaluronan synthesis seen in patients with mesothelioma is due to the release of factors from mesothelioma cells that stimulate other cells to produce hyaluronan.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417831

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

Review 1.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

2.  Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: an in vitro and in vivo study.

Authors:  Lishanthi Udabage; Gary R Brownlee; Robert Stern; Tracey J Brown
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

3.  Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites.

Authors:  R M Peterson; Q Yu; I Stamenkovic; B P Toole
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  Acidic glycosaminoglycans of abdominal mucin in a case of pseudomyxoma peritonei caused by appendiceal cancer.

Authors:  T Miyashita; K Murata; E Hoshino; H Nishiya; Y Ono; I Akaoka; O Kunii
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

5.  Expression of human hyaluronan synthases in response to external stimuli.

Authors:  A Jacobson; J Brinck; M J Briskin; A P Spicer; P Heldin
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

6.  Hyaluronan synthase expression in pleural malignant mesotheliomas.

Authors:  Naoki Kanomata; Tomoyuki Yokose; Tomoyuki Kamijo; Hiroyuki Yonou; Takahiro Hasebe; Naoki Itano; Koji Kimata; Atsushi Ochiai
Journal:  Virchows Arch       Date:  2005-02-25       Impact factor: 4.064

7.  HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway.

Authors:  Maria E Ramos-Nino; Steven R Blumen; Tara Sabo-Attwood; Harvey Pass; Michele Carbone; Joseph R Testa; Deborah A Altomare; Brooke T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  2007-09-13       Impact factor: 6.914

8.  Matrix hyaluronan alters epidermal growth factor receptor-dependent cell morphology.

Authors:  Jeanne M V Louderbough; Jose I Lopez; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2010-01-29       Impact factor: 3.405

9.  Cytokines and growth factors stimulate hyaluronan production: role of hyaluronan in epithelial to mesenchymal-like transition in non-small cell lung cancer.

Authors:  Geraldine Chow; Jordi Tauler; James L Mulshine
Journal:  J Biomed Biotechnol       Date:  2010-06-30

Review 10.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.